Listeria and botulism potential in fish forces closure of California seafood company

At the request of the U.S. Food and Drug Administration, a judge has ordered L.A. Star Seafood Company Inc., located in Los Angeles, and its owners, Sima and Sam Goldring, to halt operations until they demonstrate to the FDA that they can process food in compliance with food safety laws and regulations.

L.A. Star Seafood CompanyIn 2012, at the FDA’s request, the company recalled some of its products due to potential contamination. In 2013, the FDA inspected the L.A. Star facility, and sent the company a warning letter detailing steps the company must take to comply with the Federal Food, Drug, and Cosmetic Act and Current Good Manufacturing Practice requirements. In 2014, another inspection of the L.A. Star facility documented the company and its owners’ continued failure to comply with the law.

“The FDA takes legal action to protect the public’s health when it is necessary,” said Melinda K. Plaisier, the FDA’s associate commissioner for regulatory affairs. “This consent decree represents an agreement between the FDA and L.A. Star to ensure that if and when they reopen for business, they will be producing food that meets food safety requirements.”

The consent decree of permanent injunction requires L.A. Star to control for the presence of Listeria monocytogenes (L. mono) and Clostridium botulinum (C. bot), two disease-causing bacteria. The consent decree also requires the company to devise and implement Hazard Analysis Critical Control Point plans and Sanitation Standard Operating Procedures, and train staff in both.